US Broker Ratings

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 50% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) stands out in the healthcare sector as a formidable player in the medical care facilities industry. With a current market capitalization of $1.53 billion,..

Kestra Medical Technologies (KMTS): Investor Outlook on a Healthcare Innovator with 23.72% Upside Potential

For investors keen on exploring opportunities within the healthcare sector, Kestra Medical Technologies, Ltd. (KMTS) presents an intriguing prospect. With a market capitalization of $1.37 billion, this U.S.-based company is..

Acadia Healthcare (ACHC) Investor Outlook: Navigating Challenges and Opportunities in Behavioral Healthcare

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) stands at the crossroads of opportunity and challenge within the competitive landscape of the healthcare sector. Specializing in behavioral healthcare services, Acadia operates across..

Liquidia Corporation (LQDA) Stock Analysis: Exploring a 38% Upside Potential Amidst Robust Revenue Growth

Liquidia Corporation (NASDAQ: LQDA) stands as a compelling entity within the healthcare sector, specifically in the drug manufacturers – specialty & generic industry. Based in Morrisville, North Carolina, Liquidia focuses..

Arcutis Biotherapeutics (ARQT): Investor Outlook with a Promising 40% Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is making waves in the biotech sector with its innovative approach to dermatological treatments. As a company focused on developing and commercializing therapies for skin..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a Biotech Investment with Over 100% Potential Upside

Biohaven Ltd. (BHVN), a pioneering biopharmaceutical company, is making waves in the healthcare sector with its robust pipeline aimed at tackling some of the most challenging conditions in immunology, neuroscience,..

Innoviva, Inc. (INVA) Stock Analysis: A 48.75% Upside Potential in the Healthcare Sector

Innoviva, Inc. (NASDAQ: INVA) is capturing the attention of savvy investors with its notable 48.75% potential upside, presenting an intriguing opportunity in the healthcare sector. As a biopharmaceutical company specializing..

SS Innovations International (SSII) Growth Potential: Riding a 192.5% Revenue Surge in the Medical Devices Sector

SS Innovations International Inc. (SSII), a dynamic player in the healthcare sector, is making waves within the medical devices industry. Headquartered in Gurugram, India, this commercial-stage surgical robotics company is..

AdaptHealth Corp. (AHCO) Stock Analysis: Unveiling a 33% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors seeking to capitalize on its significant growth..

CONMED Corporation (CNMD) Stock Analysis: Potential 20% Upside Beckons Investors

Investors eyeing the healthcare sector may want to take a closer look at CONMED Corporation (NASDAQ: CNMD), a key player in the medical devices industry. Headquartered in Largo, Florida, CONMED..

Arrowhead Pharmaceuticals, Inc. (ARWR)

⚠️ No article content returned.

..

QuidelOrtho Corporation (QDEL) Stock Analysis: 74.56% Potential Upside Sparks Investor Interest

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector specializing in medical devices, has caught the attention of investors with its significant potential upside of 74.56%. Based in..

Galapagos NV (GLPG) Stock Analysis: Revenue Growth Soars Despite a Challenging Landscape

Galapagos NV (NASDAQ: GLPG), the Belgium-based biotechnology firm, has captured investor attention with its impressive revenue growth of 1,093.20%. As a specialist in oncology and immunology, Galapagos is committed to..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 44% Potential Upside in Gene Editing Revolution

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering biotechnology company, stands at the forefront of the healthcare sector with its innovative CRISPR/Cas9 gene-editing platform. Headquartered in Zug, Switzerland, the company is..

Astrana Health Inc. (ASTH) Investor Outlook: Analyst Ratings Suggest a 45% Upside Potential

Astrana Health Inc. (ASTH), a key player in the U.S. healthcare sector, is capturing investor attention with its promising growth potential and analyst ratings indicating a significant upside. Positioned within..

Xenon Pharmaceuticals Inc. (XENE) Stock Report: Exploring a Promising 18.67% Potential Upside

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology powerhouse specializing in neuroscience therapeutics, has rapidly ascended as a compelling investment opportunity within the healthcare sector. With a market capitalization of..

Recursion Pharmaceuticals (RXRX) Stock Analysis: Exploring a 91% Potential Upside in Biotechnology

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology sector with its innovative approach to drug discovery, leveraging cutting-edge technology to decode biology and chemistry. Situated at the..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Healthcare Player with a 1.59% Dividend Yield

National HealthCare Corporation (NHC), a stalwart in the healthcare sector, offers investors a robust business model centered around medical care facilities. With a market capitalization of $2.49 billion, NHC stands..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Exploring a Potential 39% Upside in the Booming Biotechnology Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is making waves in the biotechnology sector with its innovative approach to immune medicine. As a commercial-stage company, Adaptive Biotechnologies has positioned itself at the..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a Potential 67% Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find Azenta, Inc. (NASDAQ: AZTA) an intriguing prospect, especially given its potential upside of 67.17% based on the average analyst target price..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds